Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa, or rickettsiae), antigenic proteins derived from them, or synthetic constructs, administered for the prevention, amelioration, or treatment of infectious and other diseases.
Networked: 23992 relevant articles (2748 outcomes, 2891 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Hill, Adrian V S: 62 articles (01/2016 - 10/2003)
2. Centers for Disease Control and Prevention (CDC): 56 articles (06/2015 - 12/2000)
3. Rappuoli, Rino: 49 articles (01/2016 - 01/2002)
4. Poland, Gregory A: 48 articles (11/2015 - 05/2003)
5. Gilbert, Sarah C: 40 articles (01/2016 - 01/2005)
6. Schlom, Jeffrey: 37 articles (11/2015 - 01/2002)
7. Gulley, James L: 33 articles (11/2015 - 08/2003)
8. Aaby, Peter: 30 articles (05/2015 - 01/2002)
9. Subbarao, Kanta: 29 articles (01/2015 - 11/2002)
10. Esposito, Susanna: 28 articles (11/2015 - 02/2004)

Related Diseases

1. Infection
04/18/2013 - "Nevertheless, natural immunity against CMV provides some protection against infection and disease, natural history studies have defined the serological and molecular biological techniques needed for endpoints in future clinical trials of vaccines and CMV is not highly communicable, suggesting that it may not be necessary to achieve very high levels of population immunity through vaccination in order to affect transmission. "
06/01/2011 - "By taking into account the leading role of specific cellular immunity in the development of protection against the majority of dangerous and extremely dangerous infections of bacterial, viral, and rickettsial nature, the study of the above immunity should be considered as most important on estimating the body's immunological rearrangement when vaccines against respective infections are administered. "
09/01/2006 - "Preventive vaccines against HPVs 16 and 18 have been developed, and in phase III clinical trials they have demonstrated 100% efficacy for prevention of persistent infection and high risk cervical squamous intraepithelial neoplasias positive for these HPV types, suggesting that these vaccines, if made widely available, will dramatically reduce the burden of CC."
02/01/2004 - "With the use of a virtually identical study design, vaccines against Hib were shown to be highly effective in preventing invasive Hib infections but were not effective in preventing invasive infections due to S. "
01/01/2015 - "Subcutaneous vaccination with the GP-based vaccines provided significant protection against subsequent pulmonary infection with highly virulent strains of C. neoformans and C. gattii. "
2. Neoplasms (Cancer)
3. Human Influenza (Influenza)
4. Whooping Cough (Pertussis)
5. Communicable Diseases (Infectious Diseases)

Related Drugs and Biologics

1. Antigens
2. Antibodies
3. DNA (Deoxyribonucleic Acid)
4. Proteins (Proteins, Gene)
5. Influenza Vaccines (FluMist)
6. DNA Vaccines
7. Epitopes
8. Antiviral Agents (Antivirals)
9. Peptides
10. Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1. Immunotherapy
2. Drug Therapy (Chemotherapy)
3. Therapeutics
4. Transplantation (Transplant Recipients)
5. Injections